You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 49 No. 10, October 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  LETTERS TO THE EDITOR
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Pneumocystis carinii Pneumonia Associated With Solid Ectopic Corticotropin-Producing Tumors-Reply

John W. Henson, MD
Neurology Service Molecular Neuro-oncology Laboratory Massachusetts General Hospital Fruit St Boston, MA 02114

Russell W. Walker, MD
Department of Neurology Memorial Sloan-Kettering Cancer Center 1275 York Ave New York, NY 10021

Diane E. Stover, MD
Pulmonary Division Memorial Sloan-Kettering Cancer Center 1275 York St New York, NY 10021

Anna O. S. Fels, MD
Department of Psychiatry New York Hospital-Cornell Medical Center 1300 York Ave New York, NY 10021

Jai K. JALAJ, MD
97 Main St, Suite A Fishkill, NY 12524

Arch Neurol. 1992;49(10):1012.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.

—The occurrence of Pneumocystis carinii pneumonia (PCP) in patients with endogenous hypercortisolemia, as pointed out by McQuillen and Sugar, supports the hypothesis that our patients with brain tumors were predisposed to develop PCP because of glucocorticoid-induced alterations in their cellular immunity. Since our article was published, we have seen four additional cases of PCP in patients with brain tumor who were receiving high-dose steroid treatment. A second series of brain tumor patients with PCP is soon to be published.1

Another line of evidence implicating glucocorticoids in the abrogation of normal T-cell function is emerging from an understanding of their molecular pharmacology. Glucocorticoid receptors are ligand-binding transcription factors. Following steroid binding, they regulate transcription of specific cellular genes. The ability of dexamethasone to activate programmed T-cell death (apoptosis) is associated with transcriptional activation of TGF-β1 (a potent T-cell inhibitor),2 and suppression of interleukin 2 (T-cell growth factor) . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.